Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments and Licenses - Bio-Reference Purchase Price Allocation (Details)

v3.5.0.2
Acquisitions, Investments and Licenses - Bio-Reference Purchase Price Allocation (Details) - USD ($)
$ in Thousands
1 Months Ended
Aug. 31, 2015
Sep. 30, 2016
Dec. 31, 2015
Intangible assets:      
Goodwill   $ 700,526 $ 743,348
Bio-Reference      
Purchase price:      
Value of OPKO Common Stock issued to Bio-Reference shareholders $ 947,889    
Value of replacement stock options awards to holders of Bio-Reference stock options 2,259    
Total purchase price 950,148    
Current assets      
Cash and cash equivalents 15,800    
Accounts receivable 168,164    
Inventory 19,674    
Other current assets, principally deferred tax assets 100,052    
Total current assets 303,690    
Property, plant and equipment 112,457    
Intangible assets:      
Intangible assets 545,250    
Goodwill 391,991 $ 392,000  
Investments 5,326    
Other assets 13,265    
Total assets 1,371,979    
Accounts payable and accrued expenses (108,217)    
Income taxes payable (1,014)    
Lines of credit and notes payable (65,701)    
Capital lease obligations (18,293)    
Deferred tax liability (non-current) (228,606)    
Total purchase price 950,148    
Trade names | Bio-Reference      
Intangible assets:      
Intangible assets 47,100    
Customer relationships | Bio-Reference      
Intangible assets:      
Intangible assets 389,800    
Technology | Bio-Reference      
Intangible assets:      
Intangible assets 100,600    
Other intangible assets | Bio-Reference      
Intangible assets:      
Intangible assets $ 7,750